The molecular importance of ABCB5 in promoting cancer stemness and chemoresistance is underscored by their findings, which suggest that targeting LINC00963 could sensitize resistant cancer cells and improve therapeutic outcomes in OSCC patients. The gene discussed is ABCB5; the disease is cancer.